RNS Number : 7633J
Thruvision Group PLC
15 December 2022
 

RNS

15 December 2022

Thruvision Group plc

 

("Thruvision" or the "Company")

 

Blocklisting update

 

Correction to the first paragraph of the announcement made at 07:00 (RNS number: 4546J) on 13 December 2022: the number of ordinary shares for which an application has been made is 195,650 and not 196,650 as previously mentioned. The full corrected announcement is as per below. All other information was correct.

 

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market today announces, announces that an application has been made to the London Stock Exchange for the blocklisting of 195,650 ordinary shares of 1p each ("New Ordinary Shares").

 

The New Ordinary Shares will be issued from time to time pursuant to the exercise of employee share options under the Thruvision Group plc Sharesave Scheme.

 

On exercise, these shares will be issued credited as fully paid and will rank pari passu with the existing ordinary shares in issue. It is expected that admission will be granted on 16 December 2022.

 

An update to its blocklisting application is given below and on the assumption that the 195,650 shares are admitted on 16 December 2022.

 

 

Name of Company:                                              Thruvision Group plc

 

Name of Scheme:                                                 Thruvision Group plc Sharesave Scheme

 

Balance of Ordinary 1p shares under the         Nil

Scheme at 8 June 2022:

 

Number of Ordinary 1p shares issued               195,650

under the Scheme during the period:

 

Number of Ordinary 1p shares cancelled          Nil    

under the scheme during the period:

 

Balance of Ordinary 1p shares under the         195,650

Scheme at 15 December 2022:

 

At 15 December 2022 the total number of Ordinary Shares in issue with voting rights is 147,165,718.

 

No Ordinary Shares are held in treasury.

 

The above figure of 147,165,718 Ordinary Shares in the Company carrying voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

 

 

For further information please contact:

 

Thruvision Group plc                                                    

+44 (0)1235 425400

Tom Black, Executive Chairman


Colin Evans, Chief Executive




Investec Investment Banking (NOMAD & Broker)

+44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence




FTI Consulting LLP                                                          

+44 (0)20 3727 1000

Matt Dixon / Tom Blundell


 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford and Washington DC.

 

 

www.thruvision.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSBKQBNKBDBFBD